123 related articles for article (PubMed ID: 37574270)
1. Variant-specific Symptoms After COVID-19: A Hospital-based Study in Hiroshima.
Abe K; Sugiyama A; Ito N; Miwata K; Kitahara Y; Okimoto M; Mirzaev U; Kurisu A; Akita T; Ko K; Takahashi K; Kubo T; Takafuta T; Tanaka J
J Epidemiol; 2024 May; 34(5):238-246. PubMed ID: 37574270
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of characteristics and prognosis of COVID-19 patients requiring invasive mechanical ventilation during dominance of nonvariant, alpha, delta, and omicron variants in tertiary hospitals of Japan.
Sakuramoto K; Wada D; Maruyama S; Muroya T; Saito F; Nakamori Y; Kuwagata Y
BMC Infect Dis; 2024 Feb; 24(1):223. PubMed ID: 38374034
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
[TBL] [Abstract][Full Text] [Related]
4. Specific sequelae symptoms of COVID-19 of Omicron variant in comparison with non-COVID-19 patients: a retrospective cohort study in Japan.
Omori T; Hanafusa M; Kondo N; Miyazaki Y; Okada S; Fujiwara T; Kuramochi J
J Thorac Dis; 2024 May; 16(5):3170-3180. PubMed ID: 38883639
[TBL] [Abstract][Full Text] [Related]
5. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M
Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
[TBL] [Abstract][Full Text] [Related]
8. [Short-term persistent symptoms in preschool children with mild/common coronavirus disease 2019 caused by Omicron variant infection after discharge: a follow-up study].
Hu CC; Xu P; Xu L; Zhang Y; Zhou JG; Wang LB; Zhou WH; Ye L; Lu CM
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Dec; 24(12):1289-1294. PubMed ID: 36544405
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection in children evaluated in an ambulatory setting during Delta and Omicron time periods.
Smith H; Mahon A; Moss A; Rao S
J Med Virol; 2023 Jan; 95(1):e28318. PubMed ID: 36397139
[TBL] [Abstract][Full Text] [Related]
10. Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study.
Nakakubo S; Kishida N; Okuda K; Kamada K; Iwama M; Suzuki M; Yokota I; Ito YM; Nasuhara Y; Boucher RC; Konno S
Lancet Infect Dis; 2023 Nov; 23(11):1244-1256. PubMed ID: 37399831
[TBL] [Abstract][Full Text] [Related]
11. The diversity in the clinical features of children hospitalized with COVID-19 during the nonvariant, Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (B.1.1.529) variant periods of SARS CoV-2: Caution for neurological symptoms in Omicron variant.
Sahin A; Karadag-Oncel E; Buyuksen O; Ekemen-Keles Y; Ustundag G; Elvan-Tuz A; Tasar S; Didinmez-Taskirdi E; Baykan M; Kara-Aksay A; Yilmaz N; Olgac-Dundar N; Yilmaz D
J Med Virol; 2023 Mar; 95(3):e28628. PubMed ID: 36856142
[TBL] [Abstract][Full Text] [Related]
12. Symptom trajectories of post-COVID sequelae in patients with acute Delta or Omicron infection in Bergen, Norway.
Iversen A; Blomberg B; Haug K; Kittang B; Özgümüs T; Cox RJ; Langeland N
Front Public Health; 2024; 12():1320059. PubMed ID: 38504678
[TBL] [Abstract][Full Text] [Related]
13. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
[TBL] [Abstract][Full Text] [Related]
14. Risk of severe COVID-19 in unvaccinated patients during the period from wild-type to Omicron variant: real-world evidence from Japan.
Tomioka K; Uno K; Yamada M
Environ Health Prev Med; 2024; 29():10. PubMed ID: 38447970
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors of post-coronavirus disease 2019 condition among children and adolescents in Japan: A matched case-control study in the general population.
Hosozawa M; Hori M; Hayama-Terada M; Arisa I; Muto Y; Kitamura A; Takayama Y; Iso H
Int J Infect Dis; 2024 Jun; 143():107008. PubMed ID: 38484930
[TBL] [Abstract][Full Text] [Related]
16. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
Menni C; Valdes AM; Polidori L; Antonelli M; Penamakuri S; Nogal A; Louca P; May A; Figueiredo JC; Hu C; Molteni E; Canas L; Österdahl MF; Modat M; Sudre CH; Fox B; Hammers A; Wolf J; Capdevila J; Chan AT; David SP; Steves CJ; Ourselin S; Spector TD
Lancet; 2022 Apr; 399(10335):1618-1624. PubMed ID: 35397851
[TBL] [Abstract][Full Text] [Related]
17. Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations.
Canas LS; Molteni E; Deng J; Sudre CH; Murray B; Kerfoot E; Antonelli M; Rjoob K; Capdevila Pujol J; Polidori L; May A; Österdahl MF; Whiston R; Cheetham NJ; Bowyer V; Spector TD; Hammers A; Duncan EL; Ourselin S; Steves CJ; Modat M
Lancet Digit Health; 2023 Jul; 5(7):e421-e434. PubMed ID: 37202336
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant.
Boscolo-Rizzo P; Tirelli G; Meloni P; Hopkins C; Madeddu G; De Vito A; Gardenal N; Valentinotti R; Tofanelli M; Borsetto D; Lechien JR; Polesel J; De Riu G; Vaira LA
Int Forum Allergy Rhinol; 2022 Oct; 12(10):1273-1281. PubMed ID: 35286777
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and trends in persistent symptoms following COVID-19 in Japan: A nationwide cross-sectional survey.
Takamatsu A; Honda H; Miwa T; Tabuchi T; Taniguchi K; Shibuya K; Tokuda Y
J Infect Chemother; 2024 Aug; 30(8):725-733. PubMed ID: 38346670
[TBL] [Abstract][Full Text] [Related]
20. Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey.
Adorni F; Prinelli F; Bianchi F; Giacomelli A; Pagani G; Bernacchia D; Rusconi S; Maggi S; Trevisan C; Noale M; Molinaro S; Bastiani L; Fortunato L; Jesuthasan N; Sojic A; Pettenati C; Tavio M; Andreoni M; Mastroianni C; Antonelli Incalzi R; Galli M
JMIR Public Health Surveill; 2020 Sep; 6(3):e21866. PubMed ID: 32650305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
